Long-Term Diabetic Retinopathy Treatment Using Silicon Nanoneedles. [PDF]
SmallNguyen VP +7 more
europepmc +1 more source
AIF-1 Drives Corneal Neovascularization by Promoting Inflammatory Macrophage Activation via the MAPK and PI3K/AKT/mTOR Signaling Pathways. [PDF]
Invest Ophthalmol Vis SciLi Q +9 more
europepmc +1 more source
The relationship between pain intensity and anxiety, injection speed, and intraocular pressure changes during intravitreal anti-vascular endothelial growth factor injection: the observational pilot study. [PDF]
BMC OphthalmolKurt A, Altındal EU.
europepmc +1 more source
Aqueous Humor Concentration of Bevacizumab After Subconjunctival Injection in Rabbit
Journal of Ocular Pharmacology and Therapeutics, 2010 To investigate whether bevacizumab may be delivered into the anterior chamber after subconjunctival administration and its pharmacokinetics in aqueous humor.The right eye of 33 rabbits received subconjunctival injection of 2.5 mg of subconjunctival bevacizumab. Three rabbits were sacrificed at each of the following time points: 0.5, 1, 2, 4, 8, 12, 24,
Moon Jung, Kim +3 more
openaire +3 more sources
Related searches:
Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Recurrent Pterygium
Current Eye Research, 2008We report on the use of subconjunctival bevacizumab on corneal vessel density in recurrent pterygia.The charts of 5 patients with recurrent pterygium, who received subconjunctival injections of bevacizumab (2.5 mg/0.1 ml) were retrospectively reviewed. Ophthalmic evaluation included Snellen visual acuity (VA), tonometry and complete examination before ...
Igor Kaiserman, Irit Bahar
exaly +3 more sources
Subconjunctival Bevacizumab Injection for Corneal Neovascularization
Cornea, 2008To report on the clinical use of subconjunctival bevacizumab in patients with corneal neovascularization.The charts of 10 consecutive patients with corneal neovascularization who received subconjunctival injections of bevacizumab (2.5 mg/0.1 mL) were reviewed.
Igor Kaiserman, Irit Bahar
exaly +3 more sources
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization
International Ophthalmology, 2013To evaluate the effects of various doses of subconjunctival bevacizumab injections in the treatment of patients with corneal neovascularization. During the 6-month-follow-up, no significant ocular or systemic adverse events were observed related to the subconjunctival bevacizumab injection.
Suphi Acar
exaly +3 more sources
Cornea, 2011 To determine the effects on corneal neovascularization (NV) and lipid deposition after subconjunctival injection of bevacizumab in patients who had NV associated with lipid keratopathy.A case interventional study enrolled 18 patients (18 eyes) with lipid keratopathy.
Hsiao-Sang, Chu +6 more
openaire +3 more sources
This study sought to evaluate the efficacy of bevacizumab (Avastin), an anti-VEGF agent, in the reduction of corneal neovascularization in a rodent model, and compare between the effect of intraocular and subconjunctival injection.Corneal neovascularization was induced by application of a mixture of 75% silver nitrate and 25% potassium nitrate to the ...
Inbal Avisar +2 more
exaly +3 more sources
The purpose of this study is to determine the effect on endothelial cell density and morphology of combined subconjunctival and intracorneal injection of bevacizumab for the treatment of corneal neovascularization (NV). The charts and specular microscopy images of ten consecutive patients with corneal NV, who received combined subconjunctival ...
Sonia N Yeung +2 more
exaly +3 more sources